Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults
Clinical trial NCT01857869 · COMPLETED
Trial details
- NCT number
- NCT01857869
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-20
- Primary completion
- 2014-03-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.